Stockreport

Optinose Reports Fourth Quarter and Full Year 2023 Financial Results and Recent Operational Highlights [Yahoo! Finance]

OptiNose, Inc.  (OPTN) 
Last optinose, inc. earnings: 3/5 06:30 am Check Earnings Report
US:NASDAQ Investor Relations: ir.optinose.com
PDF Physicians diagnose chronic sinusitis 10 times more frequently than XHANCE's current nasal polyps indication and there is no FDA-approved medication for these patients [Read more]